IBB holdings
iShares Biotechnology ETF
Positions
252 stored of 252 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 201 | Editas Medicine, Inc. | US28106W1036 | 28106W103 | 0.025% | $2.2M | Equity (common) | Corporate | United States | USD |
| 202 | Standard BioTools, Inc. | US34385P1084 | 34385P108 | 0.024% | $2.2M | Equity (common) | Corporate | United States | USD |
| 203 | Perspective Therapeutics, Inc. | US46489V3024 | 46489V302 | 0.024% | $2.2M | Equity (common) | Corporate | United States | USD |
| 204 | Silence Therapeutics plc | US82686Q1013 | 82686Q101 | 0.022% | $2.0M | Equity (common) | Corporate | United Kingdom | USD |
| 205 | OmniAb, Inc. | US68218J1034 | 68218J103 | 0.022% | $2.0M | Equity (common) | Corporate | United States | USD |
| 206 | Atea Pharmaceuticals, Inc. | US04683R1068 | 04683R106 | 0.022% | $2.0M | Equity (common) | Corporate | United States | USD |
| 207 | Lexeo Therapeutics, Inc. | US52886X1072 | 52886X107 | 0.022% | $2.0M | Equity (common) | Corporate | United States | USD |
| 208 | Immuneering Corp. Immuneering Corp., Class A | US45254E1073 | 45254E107 | 0.021% | $1.9M | Equity (common) | Corporate | United States | USD |
| 209 | Upstream Bio, Inc. | US91678A1079 | 91678A107 | 0.020% | $1.8M | Equity (common) | Corporate | United States | USD |
| 210 | Lineage Cell Therapeutics, Inc. | US53566P1093 | 53566P109 | 0.019% | $1.7M | Equity (common) | Corporate | United States | USD |
| 211 | Anavex Life Sciences Corp. | US0327973006 | 032797300 | 0.018% | $1.6M | Equity (common) | Corporate | United States | USD |
| 212 | Fulcrum Therapeutics, Inc. | US3596161097 | 359616109 | 0.016% | $1.5M | Equity (common) | Corporate | United States | USD |
| 213 | Keros Therapeutics, Inc. | US4923271013 | 492327101 | 0.015% | $1.4M | Equity (common) | Corporate | United States | USD |
| 214 | Codexis, Inc. | US1920051067 | 192005106 | 0.015% | $1.3M | Equity (common) | Corporate | United States | USD |
| 215 | Arcturus Therapeutics Holdings, Inc. | US03969T1097 | 03969T109 | 0.014% | $1.2M | Equity (common) | Corporate | United States | USD |
| 216 | Voyager Therapeutics, Inc. | US92915B1061 | 92915B106 | 0.013% | $1.2M | Equity (common) | Corporate | United States | USD |
| 217 | Quanterix Corp. | US74766Q1013 | 74766Q101 | 0.013% | $1.2M | Equity (common) | Corporate | United States | USD |
| 218 | NovaBridge Biosciences | US44975P1030 | 44975P103 | 0.013% | $1.2M | Equity (common) | Corporate | Cayman Islands | USD |
| 219 | Larimar Therapeutics, Inc. | US5171251003 | 517125100 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 220 | Pyxis Oncology, Inc. | US7473241013 | 747324101 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 221 | Humacyte, Inc. | US44486Q1031 | 44486Q103 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 222 | Entrada Therapeutics, Inc. | US29384C1080 | 29384C108 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 223 | Caribou Biosciences, Inc. | US1420381089 | 142038108 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 224 | Tenaya Therapeutics, Inc. | US87990A1060 | 87990A106 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 225 | LENZ Therapeutics, Inc. | US52635N1037 | 52635N103 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 226 | Foghorn Therapeutics, Inc. | US3441741077 | 344174107 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 227 | Quantum-Si, Inc. | US74765K1051 | 74765K105 | 0.012% | $1.1M | Equity (common) | Corporate | United States | USD |
| 228 | AC Immune SA | CH0329023102 | Not reported | 0.011% | $1.0M | Equity (common) | Corporate | Switzerland | USD |
| 229 | Bicycle Therapeutics plc | US0887861088 | 088786108 | 0.011% | $1.0M | Equity (common) | Corporate | United Kingdom | USD |
| 230 | Neumora Therapeutics, Inc. | US6409791000 | 640979100 | 0.010% | $924K | Equity (common) | Corporate | United States | USD |
| 231 | PepGen, Inc. | US7133171055 | 713317105 | 0.009% | $807K | Equity (common) | Corporate | United States | USD |
| 232 | Lyell Immunopharma, Inc. | US55083R2031 | 55083R203 | 0.008% | $760K | Equity (common) | Corporate | United States | USD |
| 233 | ADC Therapeutics SA | CH0499880968 | Not reported | 0.008% | $716K | Equity (common) | Corporate | Switzerland | USD |
| 234 | Cellectis SA | US15117K1034 | 15117K103 | 0.007% | $669K | Equity (common) | Corporate | France | USD |
| 235 | Black Diamond Therapeutics, Inc. | US09203E1055 | 09203E105 | 0.007% | $642K | Equity (common) | Corporate | United States | USD |
| 236 | Aardvark Therapeutics, Inc. | US0029421007 | 002942100 | 0.006% | $513K | Equity (common) | Corporate | United States | USD |
| 237 | Alpha Teknova, Inc. | US02080L1026 | 02080L102 | 0.005% | $438K | Equity (common) | Corporate | United States | USD |
| 238 | Jyong Biotech Ltd. | KYG831161065 | Not reported | 0.005% | $425K | Equity (common) | Corporate | Cayman Islands | USD |
| 239 | Akero Therapeutics, Inc. Akero Therapeutics, Inc., CVR | Not reported | 009CVR044 | 0.004% | $335K | Other | Corporate | United States | USD |
| 240 | E-Mini Health Care Select Sector Index | Not reported | Not reported | 0.004% | $329K | Equity derivatives | Other | United States | USD |
| 241 | Immutep Ltd. | US45257L1089 | 45257L108 | 0.003% | $306K | Equity (common) | Corporate | Australia | USD |
| 242 | Gossamer Bio, Inc. | US38341P1021 | 38341P102 | 0.003% | $247K | Equity (common) | Corporate | United States | USD |
| 243 | Contra Chinook Therape Contra Chinook Therape, CVR | US169CVR0169 | 169CVR016 | <0.001% | $55K | Other | Corporate | United States | USD |
| 244 | Russell 2000 E-Mini Index | Not reported | Not reported | <0.001% | $45K | Equity derivatives | Other | United States | USD |
| 245 | Arcellx, Inc. Arcellx, Inc., CVR | Not reported | 039CVR014 | <0.001% | $24K | Other | Corporate | United States | USD |
| 246 | Cartesian Therapeutics, Inc. | US8162121128 | 816212112 | <0.001% | $2K | Other | Corporate | United States | USD |
| 247 | Fusion Pharmaceuticals, Inc. Fusion Pharmaceuticals, Inc., CVR | US361CVR0124 | 361CVR012 | <0.001% | $1K | Other | Corporate | Canada | USD |
| 248 | Cargo Therapeutics, Inc. Cargo Therapeutics, Inc., CVR | US141CVR0196 | 141CVR019 | 0.000% | $2 | Other | Corporate | United States | USD |
| 249 | Akouos, Inc. Akouos, Inc., CVR | US009CVR0361 | 009CVR036 | 0.000% | $2 | Other | Corporate | United States | USD |
| 250 | Third Harmonic Bio, Inc. | US88427A1079 | 88427A107 | 0.000% | $1 | Equity (common) | Corporate | United States | USD |
| 251 | OmniAb, Inc. OmniAb, Inc., 15.00 Earnout Shares | US68218J3014 | 68218J301 | 0.000% | $0 | Other | Corporate | United States | USD |
| 252 | OmniAb Operations, Inc. OmniAb, Inc., 12.50 Earnout Shares | US68218J2024 | 68218J202 | 0.000% | $0 | Other | Corporate | United States | USD |